It may not be the quickest or most flexible option, but it is built for people who want guidance, accountability, and care that goes beyond the prescription
Regular checks can uncover trends and help fine-tune medication timing
"Retatrutide, a GIP, GLP-1, and Glucagon Receptor Agonist, for Obesity." New England Journal of Medicine , 2023
Some studies have evaluated AOD 9604 in combination with other compounds, such as hyaluronic acid, to assess interactions between structural support systems and peptide-mediated signaling
For a triple-agonist like retatrutide, that monitoring cadence would likely need to be tighter, given the added glucagon-driven catabolic effects